Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Rampril tablet is indicated in the following cases. Hypertension: to lower blood pressure, either as single-drug therapy or in combination with other antihypertensive agents. Congestive heart failure: also in combination with diuretics. Treatment of patients who, within the first few days after an acute myocardial infarction, have shown clinical signs of congestive heart failure. Treatment of overt glomerular or incipient nephropathy, whether diabetic or non-diabetic. Reduction in the risk of myocardial infarction, stroke or cardiovascular death in patients with increased cardiovascular risk, such as manifest coronary heart disease (with or without a history of myocardial infarction), a history of stroke, a history of peripheral vascular disease, or diabetes mellitus accompanied by at least one other cardiovascular risk factor (microalbuminuria, hypertension, elevated total cholesterol levels, low high-density lipoprotein cholesterol levels, or smoking).

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Ramipril is an angiotensin converting enzyme (ACE) inhibitor. After hydrolysis to ramiprilat, it blocks the conversion of angiotensin I to the vasoconstrictor substance angiotensin II. Inhibition of ACE by ramipril therefore results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and decreased aldosterone secretion. In this way, ramipril exerts its antihypertensive activity. It is also effective in the management of heart failure and in reducing the risk of stroke, myocardial infarction and death from cardiovascular events. Being long acting and well tolerated, it is suitable for long term therapy.

Pregnancy & Breastfeeding

Ramipril should not be used at any point during pregnancy, so pregnancy needs to be ruled out before starting this medicine. If treatment with an ACE inhibitor is truly unavoidable, the patient should not become pregnant while taking it. Anyone planning a pregnancy should switch, ahead of time, to a different treatment in place of an ACE inhibitor. If pregnancy occurs while a patient is already on Ramipril, it should be swapped for a non-ACE-inhibitor treatment as soon as possible, since continuing otherwise puts the baby at risk of harm. Ramipril is also not recommended while breastfeeding.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Dosage of Ramipril must be adjusted according to the patient's tolerance and response. Hypertension: for the management of hypertension in adults who are not receiving a diuretic, the usual initial dose of Ramipril is 1.25 to 2.5 mg once daily. The dose is generally adjusted no more rapidly than at 2 week intervals. The usual maintenance dose in adults is 2.5 to 20 mg daily, given as a single dose or in 2 divided doses daily. If BP is not controlled with Ramipril alone, a diuretic may be added. Congestive heart failure after myocardial infarction: in this case, Ramipril therapy may be started as early as 2 days after the myocardial infarction. An initial dose of 2.5 mg twice daily is recommended, but if hypotension occurs, the dose should be reduced to 1.25 mg twice daily. Therapy is then titrated to a target dose of 5 mg twice daily. Prevention of major cardiovascular events: in this case, the recommended dose is 2.5 mg once daily for the first week of therapy and 5 mg once daily for the following 3 weeks; the dose may then be increased, as tolerated, to a maintenance dose of 10 mg once daily. Dosage in renal impairment: for patients with hypertension and renal impairment, the recommended initial dose is 1.25 mg of Ramipril once daily. Subsequent doses should be titrated according to individual tolerance and BP response, up to a maximum of 5 mg daily. For patients with heart failure and renal impairment, the recommended dose is 1.25 mg once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum of 2.5 mg twice daily, depending on clinical response and tolerability.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.